SCPX - Scorpius Holdings, Inc Total Debt to Capital

Public company logo of Scorpius Holdings, Inc. (SCPX)

The confirmed price history on the total debt-to-equity chart, which stands at 0.50, helps assess the resilience of Scorpius Holdings, Inc. (SCPX) to geopolitical risks and sanction-driven supply chain disruptions. Scorpius Holdings, Inc. (SCPX) relies on a CDMO model, creating barriers to entry for competitors by expanding its bioreactor fleet. Ownership of an integrated production base makes the business a key operational link for the release of innovative therapies.

SCPX: Scorpius Holdings Total Debt to Capital 02/21/2024 - 04/26/2025

Analytical breakdowns for Scorpius Holdings, Inc.

- price and consensus price forecast:
Price Chart Scorpius Holdings|SCPX - Forecast Levels Chart
- market capitalization statistics:
Market Capitalization Scorpius Holdings|SCPX - Value Adjusted for Debt and Cash
- book capitalization indicators:
Book Value per Share Scorpius Holdings|SCPX - Book Capitalization|Market Value to Book Value Ratio nighthawkbio.com|SCPX - Aggregate Asset Value
- company total debt and liquidity indicators:
Debt to Equity Scorpius Holdings, Inc.|SCPX - Long-Term Debt to Equity Ratio|Short-Term Debt to Capital Scorpius Holdings, Inc.|SCPX - Company Aggregate Debts|Debt to Book Value Scorpius Holdings|SCPX - Company Long-Term Loans and Borrowings|Company Current Liabilities Scorpius Holdings|Quick Ratio nighthawkbio.com
- earnings and valuation multiples information:
SCPX - Company Net Income
Basic company analysis:Scorpius Holdings
Core merchandise of Scorpius Holdings, Inc

For Scorpius Holdings, Inc. (SCPX), whose CDMO model is based on long-term contracts and stable cash flow, the total debt-to-equity ratio reflects the balance between external financing and equity. This metric compares total liabilities to the net asset value, demonstrating the degree of financial leverage and the resilience of the balance sheet structure to market volatility, which confirms the overall reliability of the issuer.

Competitor analysis for Scorpius Holdings, Inc.

Debt to Equity IQVIA|Labcorp Holdings - Aggregate Debt to Equity|Total Debt to Capital MEDP|ICLR (ICON Public Limited Company) - All Debt to Shareholders' Equity Ratio|Total Debt to Capital CRL (Charles River Laboratories)|Total Debt to Capital evotec.com EVO|FTRE - Debt to Equity|All Debt to Shareholders' Equity Ratio LFCR (Lifecore Biomedical)|OmniAb Corp (OABI) - Debt to Equity|Total Debt to Equity Ratio Inotiv Corporation|CDMO (Avid Bioservices, Inc.) - Total Debt to Capital|Total Debt to Capital catalent.com